Interaction of hantavirus nucleocapsid protein with ribosomal protein S19.

J Virol

Department of Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center, Kansas City, Kansas 66103, USA.

Published: December 2010

AI Article Synopsis

  • Hantaviruses are emerging category A pathogens from the Bunyaviridae family that have a unique way of starting translation of their mRNAs.
  • The viral nucleocapsid protein (N) binds to the 5' m7G cap of the mRNA and the 40S ribosomal subunit to initiate this process.
  • The study reveals that N interacts specifically with ribosomal protein S19 (RPS19), which helps ribosome loading on capped mRNAs for translation initiation.

Article Abstract

Hantaviruses, members of the Bunyaviridae family, are emerging category A pathogens that initiate the translation of their capped mRNAs by a novel mechanism mediated by viral nucleocapsid protein (N). N specifically binds to the mRNA 5' m7G cap and 40S ribosomal subunit, a complex of 18S rRNA and multiple ribosomal proteins. Here, we show that N specifically interacts with the ribosomal protein S19 (RPS19), located at the head region of the 40S subunit. We suggest that this N-RPS19 interaction facilitates ribosome loading on capped mRNAs during N-mediated translation initiation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2976419PMC
http://dx.doi.org/10.1128/JVI.01388-10DOI Listing

Publication Analysis

Top Keywords

nucleocapsid protein
8
ribosomal protein
8
protein s19
8
capped mrnas
8
interaction hantavirus
4
hantavirus nucleocapsid
4
protein
4
ribosomal
4
protein ribosomal
4
s19 hantaviruses
4

Similar Publications

Introduction: Alkhumra hemorrhagic fever virus (AHFV) is a newly discovered virus in the Flaviviridae family. It was discovered in 1995 among animal handlers in Saudi Arabia. AHFV spreads through close contact with infected animals and tick bites.

View Article and Find Full Text PDF

The nonsense-mediated mRNA decay (NMD) pathway triggers the degradation of defective mRNAs and governs the expression of mRNAs with specific characteristics. Current understanding indicates that NMD is often significantly suppressed during viral infections to protect the viral genome. In numerous viruses, this inhibition is achieved through direct or indirect interference with the RNA helicase UPF1, thereby promoting viral replication and enhancing pathogenesis.

View Article and Find Full Text PDF

Rational design of a triple-type HPV53/56/66 vaccine with one preferable base particle incorporating two identified immunodominant sites.

J Nanobiotechnology

January 2025

State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, Discipline of Intelligent Instrument and Equipment, Department of Experimental Medicine, School of Life Sciences, School of Public Health, Xiamen University, Xiamen, China.

The numerous high-risk carcinogenic types of human papillomavirus (HR-HPV) that lack vaccine protection underscore the urgent need to develop broader-spectrum HPV vaccines. This study addresses this need by focusing on HR-HPV types 53, 56, and 66, which are not currently targeted by existing vaccines. It introduces an effective method for their soluble expression, as well as that of their mutants, within an Escherichia coli expression system.

View Article and Find Full Text PDF

Computational Insights on the Assembly of the Dengue Virus Membrane-Capsid-RNA Complex.

J Membr Biol

January 2025

Department of Life Sciences, Presidency University, 86/1 College Street, Kolkata, 700073, India.

Dengue virus, an arbovirus from the genus Flavivirus in the family Flaviviridae, forms a nucleocapsid structure through interactions between its genome and multiple copies of the capsid protein. Experimental studies have confirmed the interaction between the viral capsid protein and lipid droplets, indicating a protein-lipid interaction. Cryo-EM studies show that in immature viruses, the nucleocapsid is located close to the viral membrane.

View Article and Find Full Text PDF

Recombinant expression systems for production of stabilised virus-like particles as next-generation polio vaccines.

Nat Commun

January 2025

Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, UK.

Polioviruses have caused crippling disease in humans for centuries, prior to the successful development of vaccines in the mid-1900's, which dramatically reduced disease prevalence. Continued use of these vaccines, however, threatens ultimate disease eradication and achievement of a polio-free world. Virus-like particles (VLPs) that lack a viral genome represent a safer potential vaccine, although they require particle stabilization.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!